U.S. News

BRIEF-Cipher gets FDA approval for CIP-TRAMADOL ER


May 10 (Reuters) - Cipher Pharmaceuticals Inc: * Achieves major milestone with FDA approval for CIP-TRAMADOL ER * Says currently preparing for the U.S. commercial launch of the product ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.